Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Abadi ATB |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. |
2017 |
World J. Gastroenterol. |
pmid:29085187
|
Lai YC et al. |
Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. |
2004 |
World J. Gastroenterol. |
pmid:15052680
|
Ji F et al. |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. |
2006 |
World J. Gastroenterol. |
pmid:16586550
|
Molina-Infante J and Gisbert JP |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:25132750
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Sereni G et al. |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22969227
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Wang HH et al. |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. |
2005 |
World J. Gastroenterol. |
pmid:15786549
|
Aydemir S et al. |
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15682477
|
Shimbo I et al. |
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. |
2005 |
World J. Gastroenterol. |
pmid:16437727
|
Wang CH et al. |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China. |
2015 |
World J. Gastroenterol. |
pmid:26494972
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Mohammadi M et al. |
Helicobacter pylori antibiotic resistance in Iran. |
2005 |
World J. Gastroenterol. |
pmid:16273615
|
Nishida T et al. |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. |
2014 |
World J. Gastroenterol. |
pmid:24764674
|
Gao XZ et al. |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. |
2010 |
World J. Gastroenterol. |
pmid:20818821
|
Farshad S et al. |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. |
2010 |
World J. Gastroenterol. |
pmid:21128326
|